1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption Analysis
4.2. Recent Product Approvals
4.3. Regulatory Landscape
4.4. Reimbursement Scenario
4.5. Supply Chain Analysis
4.6. Porter’s Analysis
4.7. PESTLE Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Animal Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growing Healthcare Expenditure
5.2.2. Historic and Current Revenue of Key Players
5.2.3. Increasing Adoption of Diagnostic Tools
5.2.4. Rising Incidences of Infectious Diseases
5.2.5. Introduction of New and Advance Reagent Kits and Devices
5.2.6. High Cost of Diagnostic kits
5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools
5.2.8. Strategic Collaboration among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Reagent Kits
6.1.2. By Disease
6.1.3. By End User
6.1.4. By Country
6.2. 2022 Market Scenario
7. Global Market Market Outlook, 2019 - 2032
7.1. Historical Market Value (US$ Mn) Analysis, 2019 - 2023
7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Market Outlook, 2019 - 2032, By Reagent Kits
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2019 - 2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2024–2032
8.3.1. Rapid Testing Kits
8.3.2. Assay Based Kits
8.4. Market Attractiveness Analysis by Reagent Kits
9. Global Market Market Outlook, 2019 - 2032, By Disease
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019 - 2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024–2032
9.3.1. WSSV (White Spot Syndrome Virus)
9.3.2. TSV (Taura Syndrome Virus)
9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)
9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
9.3.5. HPV (Hepatopancreatic Parvovirus)
9.3.6. MBV (Monodon Baculovirus)
9.3.7. IMNV (Infectious Myonecrosis Virus)
9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
9.3.9. MoV (Mourilyan Virus)
9.3.10. Early Mortality Syndrome (EMS)
9.4. Market Attractiveness Analysis by Disease
10. Global Market Market Outlook, 2019 - 2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by End User, 2019 - 2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024–2032
10.3.1. Fisheries
10.3.2. Aquaculture Laboratories
10.3.3. Marine Laboratories
10.3.4. Education and Research Institutes
10.3.5. Others
10.4. Market Attractiveness Analysis by End User
11. Global Market Market Outlook, 2019 - 2032, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019 - 2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis by Region
12. North America Market Market Outlook, 2019 - 2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019 - 2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Reagent Kits
12.3.3. By Disease
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Reagent Kits
12.4.3. By Disease
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Market
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Reagent Kits
12.8.1.2.2. By Disease
12.8.1.2.3. By End User
12.8.2. Canada Market
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Reagent Kits
12.8.2.2.2. By Disease
12.8.2.2.3. By End User
13. Latin America Market Market Outlook, 2019 - 2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 - 2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Reagent Kits
13.3.3. By Disease
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Reagent Kits
13.4.3. By Disease
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Reagent Kits
13.8.1.2.2. By Disease
13.8.1.2.3. By End User
13.8.2. Brazil Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Reagent Kits
13.8.2.2.2. By Disease
13.8.2.2.3. By End User
13.8.3. Argentina Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Reagent Kits
13.8.3.2.2. By Disease
13.8.3.2.3. By End User
14. Europe Market Market Outlook, 2019 - 2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019 - 2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Reagent Kits
14.3.3. By Disease
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Reagent Kits
14.4.3. By Disease
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Reagent Kits
14.8.1.2.2. By Disease
14.8.1.2.3. By End User
14.8.2. Italy Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Reagent Kits
14.8.2.2.2. By Disease
14.8.2.2.3. By End User
14.8.3. France Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Reagent Kits
14.8.3.2.2. By Disease
14.8.3.2.3. By End User
14.8.4. U.K. Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Reagent Kits
14.8.4.2.2. By Disease
14.8.4.2.3. By End User
14.8.5. Spain Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Reagent Kits
14.8.5.2.2. By Disease
14.8.5.2.3. By End User
14.8.6. BENELUX Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Reagent Kits
14.8.6.2.2. By Disease
14.8.6.2.3. By End User
14.8.7. Russia Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Reagent Kits
14.8.7.2.2. By Disease
14.8.7.2.3. By End User
15. East Asia Market Market Outlook, 2019 - 2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019 - 2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Reagent Kits
15.3.3. By Disease
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Reagent Kits
15.4.3. By Disease
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Reagent Kits
15.8.1.2.2. By Disease
15.8.1.2.3. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Reagent Kits
15.8.2.2.2. By Disease
15.8.2.2.3. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Reagent Kits
15.8.3.2.2. By Disease
15.8.3.2.3. By End User
16. South Asia Market Market Outlook, 2019 - 2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 - 2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Reagent Kits
16.3.3. By Disease
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Reagent Kits
16.4.2. By Disease
16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Reagent Kits
16.8.1.2.2. By Disease
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Reagent Kits
16.8.2.2.2. By Disease
16.8.2.2.3. By End User
16.8.3. Malaysia Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Reagent Kits
16.8.3.2.2. By Disease
16.8.3.2.3. By End User
16.8.4. Thailand Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Reagent Kits
16.8.4.2.2. By Disease
16.8.4.2.3. By End User
17. Oceania Market 2014-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 - 2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Reagent Kits
17.3.3. By Disease
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Reagent Kits
17.4.2. By Disease
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Australia Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Reagent Kits
17.8.1.2.2. By Disease
17.8.1.2.3. By End User
17.8.2. New Zealand Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Reagent Kits
17.8.2.2.2. By Disease
17.8.2.2.3. By End User
18. Middle East and Africa (MEA) Market Market Outlook, 2019 - 2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019 - 2023
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024–2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. North Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Reagent Kits
18.3.3. By Disease
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Reagent Kits
18.4.3. By Disease
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Reagent Kits
18.8.1.2.2. By Disease
18.8.1.2.3. By End User
18.8.2. Türkiye Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Reagent Kits
18.8.2.2.2. By Disease
18.8.2.2.3. By End User
18.8.3. South Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Reagent Kits
18.8.3.2.2. By Disease
18.8.3.2.3. By End User
18.8.4. North Africa Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Reagent Kits
18.8.4.2.2. By Disease
18.8.4.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Branding and Promotional Strategies
20.3. Key Development Analysis
20.4. Competition Deep Dive
20.4.1. HiMedia Laboratories
20.4.1.1. Overview
20.4.1.2. Product Portfolio
20.4.1.3. Sales Footprint
20.4.1.4. Key Financials
20.4.1.5. SWOT Analysis
20.4.1.6. Strategy Overview
20.4.1.6.1. Marketing Strategy
20.4.1.6.2. Product Strategy
20.4.1.6.3. Channel Strategy
20.4.2. HiMedia Laboratories
20.4.2.1. Overview
20.4.2.2. Product Portfolio
20.4.2.3. Sales Footprint
20.4.2.4. Key Financials
20.4.2.5. SWOT Analysis
20.4.2.6. Strategy Overview
20.4.2.6.1. Marketing Strategy
20.4.2.6.2. Product Strategy
20.4.2.6.3. Channel Strategy
20.4.3. Speedy Assay Sdn Bhd
20.4.3.1. Overview
20.4.3.2. Product Portfolio
20.4.3.3. Sales Footprint
20.4.3.4. Key Financials
20.4.3.5. SWOT Analysis
20.4.3.6. Strategy Overview
20.4.3.6.1. Marketing Strategy
20.4.3.6.2. Product Strategy
20.4.3.6.3. Channel Strategy
20.4.4. REAGEN LLC
20.4.4.1. Overview
20.4.4.2. Product Portfolio
20.4.4.3. Sales Footprint
20.4.4.4. Key Financials
20.4.4.5. SWOT Analysis
20.4.4.6. Strategy Overview
20.4.4.6.1. Marketing Strategy
20.4.4.6.2. Product Strategy
20.4.4.6.3. Channel Strategy
20.4.5. FUJIKURA KASEI CO., LTD.
20.4.5.1. Overview
20.4.5.2. Product Portfolio
20.4.5.3. Sales Footprint
20.4.5.4. Key Financials
20.4.5.5. SWOT Analysis
20.4.5.6. Strategy Overview
20.4.5.6.1. Marketing Strategy
20.4.5.6.2. Product Strategy
20.4.5.6.3. Channel Strategy
20.4.6. GeneReach Biotechnology Corp.
20.4.6.1. Overview
20.4.6.2. Product Portfolio
20.4.6.3. Sales Footprint
20.4.6.4. Key Financials
20.4.6.5. SWOT Analysis
20.4.6.6. Strategy Overview
20.4.6.6.1. Marketing Strategy
20.4.6.6.2. Product Strategy
20.4.6.6.3. Channel Strategy
20.4.7. Thermo Fisher Scientific
20.4.7.1. Overview
20.4.7.2. Product Portfolio
20.4.7.3. Sales Footprint
20.4.7.4. Key Financials
20.4.7.5. SWOT Analysis
20.4.7.6. Strategy Overview
20.4.7.6.1. Marketing Strategy
20.4.7.6.2. Product Strategy
20.4.7.6.3. Channel Strategy
20.4.8. Lab - Ind Resource Sdn Bhd.
20.4.8.1. Overview
20.4.8.2. Product Portfolio
20.4.8.3. Sales Footprint
20.4.8.4. Key Financials
20.4.8.5. SWOT Analysis
20.4.8.6. Strategy Overview
20.4.8.6.1. Marketing Strategy
20.4.8.6.2. Product Strategy
20.4.8.6.3. Channel Strategy
20.4.9. SUREBIO
20.4.9.1. Overview
20.4.9.2. Product Portfolio
20.4.9.3. Sales Footprint
20.4.9.4. Key Financials
20.4.9.5. SWOT Analysis
20.4.9.6. Strategy Overview
20.4.9.6.1. Marketing Strategy
20.4.9.6.2. Product Strategy
20.4.9.6.3. Channel Strategy
20.4.10. Auro Biotechnologies Pvt. Ltd.
20.4.10.1. Overview
20.4.10.2. Product Portfolio
20.4.10.3. Sales Footprint
20.4.10.4. Key Financials
20.4.10.5. SWOT Analysis
20.4.10.6. Strategy Overview
20.4.10.6.1. Marketing Strategy
20.4.10.6.2. Product Strategy
20.4.10.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
